The Government has not responded to a new protected disclosure on chemical exposures within the Air Corps.
The disclosure was made by a whistleblower, who says he is chronically ill, due to his experiences at Casement Aerodrome, the Irish Examiner can reveal.
The protected disclosure, seen by this newspaper, was submitted to the Department of Defence last December, but the whistleblower has not been contacted since, bar an acknowledgement that his disclosure was received.
In the December 2017 disclosure, the former member of staff echoes previous submissions to the Government. He says he was doused in chemicals by other recruits colleagues, as an initiation, and was frequently exposed to various chemicals as part of his duties in the engine shop at Casement Aerodrome, Baldonnel.
He alleges that he became ill while still serving in the Air Corps, but was bullied and mistreated by superiors for his frequent absences, due to illnesses he believes were caused by his working environment.
Read full article on Irish Examiner website below…
To ask the Taoiseach and Minister for Defence if he has received a protected disclosure from a member of the Defence Forces (details supplied); if he has responded to the disclosure; and the action that has been taken on foot of the disclosure. — Aengus Ó Snodaigh. [27762/18]
To be clear Minister Paul Kehoe & Taoiseach Leo Varadkar received this Protected Disclosure in December 2017, issued a receipt and have ignored since.
A research team from the University of Newcastle (Australia) has completed an investigation into whether there is an association between adverse health and an involvement in F-111 fuel tank deseal/reseal activities and, if so, the nature and strength of that association.
The current health status of those workers was compared with the health of groups of workers with similar backgrounds from Amberley and Richmond air bases.
Yield of literature review
Associations between exposure and health outcomes
Multiple Sclerosis, Motor Neurone Disease and Other Neurological Examinations
Other Neurological Outcomes
Reproductive Health Effects
Other health effects
Health and the Manufacture and Maintenance of Aircraft
Measurement of exposure and outcomes
Measurement of Neuropsychological Deficits
Summary of Results and Implications for General Health and Medical Study
Multiple Sclerosis, Motor Neurone Disease and other Neurological Effects
When the RAAF and the Australian Government discovered there was a chemical exposure problem and associated health problems amongst aircraft maintenance personnel they initiated some health studies one of which became known as SHOAMP. These studies are ongoing and report every 4 years to the best of our knowledge.
Australia does have a Department of Veteran Affairs and operates schemes whereby medical & financial support are in place to support RAAF personnel affected by the F1-11 Deseal / Reseal program.
These schemes are far from perfect and are a cause of ongoing stress amongst Australian survivors but obviously preferable to Ireland where Irish Air Corps sick personnel have to risk their home to take the the state to court while our compassionate medically qualified Taoiseach (Prime Minister) Leo Varadkar recently refused medical help for Air Corps personnel in the Irish parliament and goaded sick survivors to sue.
Any person who served in the Irish Army Air Corps needs to read the above document which is the 2003 SHOAMP report. Unfortunately many links on the Australian DVA website are down. As we find newer SHOAMP reports we will make them available.
Epichlorohydrin is mainly used in the production of epoxy resins. Acute (short-term) inhalation exposure to epichlorohydrin in the workplace has caused irritation to the eyes, respiratory tract, and skin of workers.
At high levels of exposure, nausea, vomiting, cough, labored breathing, inflammation of the lung, pulmonary edema, and renal lesions may be observed in humans.
Chronic (long-term) occupational exposure of humans to epichlorohydrin in air is associated with high levels of respiratory tract illness and hematological effects.
Damage to the nasal passages, respiratory tract and kidneys have been observed in rodents exposed to epichlorohydrin by inhalation for acute or chronic duration. An increased incidence of tumors of the nasal cavity has been observed in rats exposed by inhalation. EPA has classified epichlorohydrin as a Group B2, probable human carcinogen.
Please Note: The main sources of information for this fact sheet are EPA's IRIS (2), which contains information on inhalation chronic toxicity and carcinogenic effects of epichlorohydrin and the RfC, and unit cancer risk estimate for inhalation exposure, and the Health and Environmental Effects Profile for Epichlorohydrin. (1)
The primary use of epichlorohydrin is in the production of epoxy resins used in coatings, adhesives, and plastics. (1,5)
Epichlorohydrin is also used in the manufacture of synthetic glycerine, textiles, paper, inks and dyes, solvents, surfactants, and pharmaceuticals. (1)
Epichlorohydrin is also listed as an inert ingredient in commercial pesticides. (1)
Sources and Potential Exposure
Individuals are most likely to be exposed to epichlorohydrin in the workplace. (1)
Epichlorohydrin may be released to the ambient air during its production and use. (1)
Accidental releases to waterways may expose the general public to epichlorohydrin. (1)
Assessing Personal Exposure
No information was located concerning the measurement of personal exposure to epichlorohydrin.
Health Hazard Information
Acute inhalation exposure to epichlorohydrin in the workplace has caused irritation to the eyes, respiratory tract, and skin of workers. At high levels of exposure, nausea, vomiting, cough, labored breathing, chemical pneumonitis (inflammation of the lung), pulmonary edema, and renal lesions may be observed in humans. (1,2)
Dermal contact with epichlorohydrin may result in irritation and burns of the skin in humans and animals.(1)
In rats and mice acutely exposed to epichlorohydrin by inhalation, nasal and lower respiratory tract irritation and lesions, hemorrhage, and severe edema have been observed. Renal degeneration and CNS depression with paralysis of respiration and cardiac arrest have also resulted from acute inhalation exposure in animals. (1-3)
Tests involving acute exposure of rats, mice and rabbits have demonstrated epichlorohydrin to have high acute toxicity from inhalation, oral, and dermal exposure. (4)
Chronic Effects (Noncancer):
Chronic occupational exposure of humans to epichlorohydrin in air is associated with high levels of respiratory tract illness and hematological effects (decreased hemoglobin concentration and decreased erythrocyte and leukocyte counts). (1,5)
Chronic inhalation exposure has been observed to cause pulmonary effects including inflammation and degenerative changes in the nasal epithelia, severe lung congestion, and pneumonia in rats and mice. Effects to the kidneys were also observed. (1,2)
Hepatic damage, hematological effects, myocardial changes, and damage to the CNS have been reported in chronically exposed rats. (1,5)
The Reference Concentration (RfC) for epichlorohydrin is 0.001 milligrams per cubic meter (mg/m3) basedon changes in the nasal turbinates in rats and mice. The RfC is an estimate (with uncertainty spanningperhaps an order of magnitude) of a continuous inhalation exposure to the human population (including sensitive subgroups), that is likely to be without appreciable risk of deleterious noncancer effects during a lifetime. It is not a direct estimator of risk but rather a reference point to gauge the potential effects. At exposures increasingly greater than the RfC, the potential for adverse health effects increases. Lifetime exposure above the RfC does not imply that an adverse health effect would necessarily occur. (2)
EPA has medium confidence in the study on which the RfC was based because of the inflammation in the respiratory tract of control and exposed animals although it was well conducted and contained detailed histopathological examinations of numerous tissues including the respiratory tract; medium confidence in the database because chronic studies that adequately address the respiratory system and a two-generation reproductive study are lacking and the only chronic inhalation study is confounded by severe nasal inflammation in the controls; and, consequently, medium confidence in the RfC. (2)
The provisional Reference Dose (RfD) for epichlorohydrin is 0.002 milligrams per kilogram body weight per day (mg/kg/d) based on kidney effects in rats. The provisional RfD is a value that has had some form of Agency review, but it does not appear on IRIS (6)
In humans occupationally exposed to epichlorohydrin, effects on sperm counts, hormone levels, and fertility have been not detected. (1,2)
Epichlorohydrin has been demonstrated to reduce fertility in male rats when inhaled or administered orally.(1-3)
Teratogenic effects (birth defects) have not been observed in studies of rodents exposed by inhalation or ingestion. (1,2,5)
An increased incidence of lung cancer mortality (not statistically significant) was reported in one study of workers exposed to epichlorohydrin. (1,2)
An increased incidence of tumors of the nasal cavity has been observed in rats exposed to epichlorohydrin by inhalation. (1,2,5)
An increased incidence of forestomach tumors has been reported in rats exposed via gavage (experimentally placing the chemical in the stomach) and in drinking water. Mice have exhibited local tumors when exposed by subcutaneous injection. (1-3,5)
EPA has classified epichlorohydrin as a Group B2, probable human carcinogen. (2)
EPA uses mathematical models, based on human and animal studies, to estimate the probability of a EPA uses mathematical models, based on human and animal studies, to estimate the probability of a person developing cancer from breathing air containing a specified concentration of a chemical. EPA calculated an inhalation unit risk estimate of 1.2 × 10-6 (µg/m3)-1. EPA estimates that, if an individual were to continuously breathe air containing epichlorohydrin at an average of 0.8 µg/m3 (0.0008 mg/m3) over hisor her entire lifetime, that person would theoretically have no more than a one-in-a-million increasedchance of developing cancer as a direct result of breathing air containing this chemical. Similarly, EPA estimates that breathing air containing 8.0 µg/m3 (0.008 mg/m3) would result in not greater than a one in-a-hundred thousand increased chance of developing cancer, and air containing 80.0 µg/m3 (0.08mg/m3) would result in not greater than a one-in-ten thousand increased chance of developing cancer. Fora detailed discussion of confidence in the potency estimates, please see IRIS. (2)
EPA has calculated an oral cancer slope factor of 9.9 x 10-3 (mg/kg/d)-1. (2)
The chemical formula for epichlorohydrin is C3H5OCl, and its molecular weight is 92.53 g/mol. (1,7)
Epichlorohydrin is a volatile and flammable clear liquid at room temperature and is insoluble in water.(1,2,7)
The threshold for odor perception of epichlorohydrin is 0.93 parts per million (ppm). Epichlorohydrin has a pungent, garlicky, sweet odor. (2,8) The vapor pressure for epichlorohydrin is 22 mm Hg at 30 °C. (1)
Read the full EPA (USA) PDF on the above Hazardous Air Pollutant with references below.